Patents
New Targeted Genetics Patent Provides Broad Coverage of Vectors Based on AAV Serotype 1
Published in Gene Therapy Weekly, March 22nd, 2007
Targeted Genetics Corporation (NASDAQ: TGEN) today announced the issuance of an additional patent covering the company's adeno-associated virus (AAV) vector technology. The patent, U.S. #7,186,552 titled "Adeno-Associated Virus (AAV) Serotype I Nucleic Acid Sequences, Vectors and Host Cells Containing Same" describes the use of AAV vectors that contain the inverted terminal repeat (ITR) and capsid sequences derived from AAV serotype 1 (AAV1) and host cells transduced with such vectors. The patent was issued to the University of Pennsylvania and is exclusively licensed to Targeted Genetics.
"This patent provides additional coverage for our AAV1 vector platform. Our...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2007-03-22)
More Articles from Gene Therapy Weekly
- Drug Delivery
New Study Titled Drug Delivery Systems Estimates That the US Drug Delivery Market Value Might Reach Nearly $85 Billion By 2010 - Gene Therapy
Amsterdam Molecular Therapeutics BV receives global rights to develop and commercialize AMT-020 for acute intermittent porphyria - Gene Therapy
Sigma-Aldrich Launches MISSION siRNA Druggable Genome Libraries - Patents
INEX and Alnylam Announce Allowance of New U.S. Patent Covering Delivery of RNAi Therapeutics - Cancer Gene Therapy
Data on cancer gene therapy described by investigators at Chiba Cancer Center Research Institute, Division of Pathology - Cancer Gene Therapy
Data on cancer gene therapy detailed by researchers at Uppsala University, Immunology Division - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
